XOMA Royalty Corp (XOMA)
Pharmaceutical Preparations · Healthcare · $498M
Intrinsic Value (Consensus)
$19.53
Current Price
$41.78
Margin of Safety
-53.3%
53.3% Above Intrinsic Value
Value: $20
Price: $42
Valuation Model Estimates
Current Price: $41.78
DCF (Discounted Cash Flow)
$3.77
Graham Number
$15.22
Earnings Power Value
$14.17
Relative Value (P/E)
$29.20
Dividend Discount Model
Not applicable
—
Consensus Value
$19.53
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
63
Profitability
25/25
Strength
15/25
Valuation
7/25
Growth
16/25
Financial Health Signals
Elevated debt — Debt/Equity ratio is 115%
Strong profitability — ROE of 38% (above 20% is excellent)
Key Financials
- EPS (TTM)
- $1.46
- EPS (Forward)
- $1.53
- Book Value
- $7.05
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 37.8%
- Debt/Equity
- 115%
- Revenue Growth
- 55.6%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance